Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy
Aldose reductase pathway inhibition improves NCV slowing and small myelinated nerve fiber loss in DPN in humans, but >80% suppression of nerve sorbitol content is required. Thus...